InsidersTradesSigma
온코닉테라퓨틱스 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 온코닉테라퓨틱스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has logged 6 reports. Market capitalisation: €504.5bn. The latest transaction was filed on 12 June 2026 (Sale). Among the most active insiders: 김정훈. All data is free.
6
Insider Decl.
n/a
Thresholds
€587,929
3 ops.
Buy Volume
€257,169
2 ops.
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,787 of 28,199 companies
64.5
score / 100
Value34
Quality95
FCF yld1.8%
Earn yld2.5%
EV/EBITDA44.2x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 June 2026
Declarations6 total
6 of 6 declarations
About 온코닉테라퓨틱스
Onconic Therapeutics is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments for serious diseases.